Zentalis Pharmaceuticals Llc (ZNTL) — Strategic Asset Allocation Index
Zentalis Pharmaceuticals Llc (ZNTL) has a Strategic Asset Allocation Index of 0.0% as of December 2023. Strategic assets (PP&E of $- plus long-term investments of $0.00) total $0.00, measured against net assets of $437.39 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Zentalis Pharmaceuticals Llc Strategic Asset Allocation Index (2018–2023)
This chart shows how Zentalis Pharmaceuticals Llc's Strategic Asset Allocation Index has evolved across 6 annual periods from 2018 to 2023. As of December 2023, the index stands at 0.0%, representing strategic assets of $0.00 against net assets of $437.39 Million USD. Explore ZNTL cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Zentalis Pharmaceuticals Llc (2018–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Zentalis Pharmaceuticals Llc from 2018 to 2023, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ZNTL market cap.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 0.0% | $0.00 | $- | $0.00 | $437.39 Million | ▼ -6.7 pp |
| 2022 | 6.7% | $28.92 Million | $7.71 Million | $21.21 Million | $434.02 Million | ▼ -5.9 pp |
| 2021 | 12.5% | $45.64 Million | $8.15 Million | $37.49 Million | $364.48 Million | ▲ +11.4 pp |
| 2020 | 1.1% | $3.62 Million | $3.62 Million | $0.00 | $333.38 Million | ▼ -3.1 pp |
| 2019 | 4.1% | $2.84 Million | $2.84 Million | $- | $68.42 Million | ▲ +3.3 pp |
| 2018 | 0.8% | $260.00K | $260.00K | $- | $32.31 Million | — |